For help on how to get the results you want, see our search tips.
8404 results
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Sixmo (updated)
Buprenorphine hydrochloride, Opioid-Related Disorders
Date of authorisation: 19/06/2019,
, Revision: 1, Authorised, Last updated: 23/10/2020
-
List item
Human medicine European public assessment report (EPAR): Adrovance (updated)
alendronate sodium trihydrate, colecalciferol, Osteoporosis, Postmenopausal
Date of authorisation: 04/01/2007, Revision: 21, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Rasagiline ratiopharm (updated)
rasagiline, Parkinson Disease
Date of authorisation: 12/01/2015, Revision: 7, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Beovu (updated)
brolucizumab, Wet Macular Degeneration
Date of authorisation: 13/02/2020,, Revision: 1, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Azilect (updated)
rasagiline, Parkinson Disease
Date of authorisation: 21/02/2005, Revision: 21, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Briviact (in Italy: Nubriveo) (updated)
Brivaracetam, Epilepsy
Date of authorisation: 13/01/2016,, Revision: 9, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Glyxambi (updated)
empagliflozin, linagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 11/11/2016,, Revision: 10, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Sunosi (updated)
solriamfetol hydrochloride, Narcolepsy, Sleep Apnea, Obstructive
Date of authorisation: 16/01/2020,, Revision: 1, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Actavis (updated)
zoledronic acid monohydrate, Fractures, Bone
Date of authorisation: 20/04/2012,
, Revision: 13, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Jalra (updated)
vildagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 18/11/2008, Revision: 20, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Feraccru (updated)
ferric maltol, Anemia, Iron-Deficiency
Date of authorisation: 18/02/2016, Revision: 11, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Luminity (updated)
perflutren, Echocardiography
Date of authorisation: 20/09/2006, Revision: 14, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Efient (updated)
prasugrel, Acute Coronary Syndrome, Angina, Unstable, Myocardial Infarction
Date of authorisation: 24/02/2009, Revision: 21, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Synjardy (updated)
empagliflozin, metformin, Diabetes Mellitus, Type 2
Date of authorisation: 27/05/2015,, Revision: 17, Authorised, Last updated: 21/10/2020
-
List item
Human medicine European public assessment report (EPAR): Jardiance (updated)
empagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 22/05/2014, Revision: 19, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Duavive (updated)
oestrogens conjugated, bazedoxifene, Postmenopause
Date of authorisation: 16/12/2014, Revision: 11, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Edistride (updated)
dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Date of authorisation: 09/11/2015, Revision: 13, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Aubagio (updated)
Teriflunomide, Multiple Sclerosis
Date of authorisation: 26/08/2013, Revision: 16, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Carmustine Obvius (updated)
carmustine, Hodgkin Disease, Lymphoma, Non-Hodgkin
Date of authorisation: 18/07/2018,, Revision: 5, Authorised, Last updated: 21/10/2020
-
List item
Human medicine European public assessment report (EPAR): Ristfor (updated)
sitagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2010, Revision: 20, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 15/11/2015,, Revision: 11, Authorised, Last updated: 21/10/2020
-
List item
Human medicine European public assessment report (EPAR): Eptifibatide Accord (updated)
eptifibatide, Myocardial Infarction
Date of authorisation: 11/01/2016,, Revision: 3, Authorised, Last updated: 21/10/2020
-
List item
Human medicine European public assessment report (EPAR): Hemangiol (updated)
propranolol hydrochloride, Hemangioma
Date of authorisation: 23/04/2014, Revision: 5, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Actrapid (updated)
human insulin, Diabetes Mellitus
Date of authorisation: 07/10/2002, Revision: 17, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Pregabalin Pfizer (updated)
pregabalin, Anxiety Disorders, Epilepsy
Date of authorisation: 10/04/2014, Revision: 20, Authorised, Last updated: 20/10/2020